Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 MeSH Descriptor Data 2026


MeSH Heading
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Tree Number(s)
D20.215.894.815.455
D20.215.894.899.498.500
Unique ID
D000068857
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068857
Scope Note
A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from human papillomaviruses of these subtypes.
Entry Term(s)
Gardasil
HPV L1 Vaccine, Quadrivalent 6,11,16,18
Human Papillomavirus Vaccine L1, Type 6,11,16,18
Human Papillomavirus Vaccine L1, Types 6,11,16,18
Registry Numbers
0
Public MeSH Note
2016; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT (TYPES 6, 11, 16, 18) was indexed under PAPILLOMAVIRUS VACCINES 2006-2015
History Note
2016 (2006)
Date Introduced
2016/01/01
Last Updated
2021/06/30
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Preferred
Human Papillomavirus Vaccine L1, Types 6,11,16,18 Narrower
Gardasil Narrower
page delivered in 0.125s